½ÃÀ庸°í¼­
»óǰÄÚµå
1671948

¸é¿ªÁ¶Á÷È­ÇÐ ½ÃÀå : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°

Immunohistochemistry Market, By Product, By Application, By End User, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¸é¿ªÁ¶Á÷È­ÇÐ ¼¼°è ½ÃÀåÀº 2025³â¿¡ 30¾ï 7,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2032³â¿¡´Â 48¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025³âºÎÅÍ 2032³â±îÁö CAGR 6.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í¼­ ¹üÀ§ º¸°í¼­ »ó¼¼ ³»¿ë
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 30¾ï 7,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£ : 2025-2032³â CAGR 6.70% 2032³â °¡Ä¡ ¿¹Ãø 48¾ï 4,000¸¸ ´Þ·¯
±×¸². ¸é¿ªÁ¶Á÷È­ÇÐ ½ÃÀå Á¡À¯À²(%), 2025³â, Áö¿ªº°
Immunohistochemistry Market-IMG1

¸é¿ªÁ¶Á÷È­ÇÐ(IHC)Àº »ýü Á¶Á÷ ³» Ç׿ø¿¡ ƯÀÌÀûÀ¸·Î °áÇÕÇÏ´Â Ç×üÀÇ ¿ø¸®¸¦ ÀÌ¿ëÇÏ¿© Á¶Á÷ ÀýÆíÀÇ ¼¼Æ÷ ³» Ç׿øÀ» °ËÃâÇϱâ À§ÇØ »ç¿ëµÇ´Â ±â¼ú·Î, Á¤»ó ¹× Áúº´ Á¶Á÷ ³» Ç¥Àû Ç׿øÀÇ ºÐÆ÷¿Í ´õºÒ¾î ¹ÙÀÌ¿À¸¶Ä¿ÀÇ ¼¼Æ÷ À¯Çü ¹× À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ¾î Áúº´ Áø´Ü, ¿¹ÈÄ Æò°¡, ¿¹Ãø ÀÇ·á, ¸ÂÃã ÀÇ·á¿¡ À¯¿ëÇÕ´Ï´Ù. IHC´Â Ç×ü¿Í Ç׿øÀÇ Ä£È­·ÂÀ» ÀÌ¿ëÇÏ¿© Á¶Á÷ »ùÇÃÀÇ ¼¼Æ÷ ³» ƯÁ¤ ´Ü¹éÁúÀ» Çö¹Ì°æÀûÀ¸·Î °¡½ÃÈ­ÇÏ¿© ¼¼Æ÷ À¯Çü ½Äº° ¹× »ýüºÐÀÚÀÇ ±¹¼ÒÈ­¸¦ º¸Á¶ÇÕ´Ï´Ù. Á¤È®Çϰí ÀçÇö¼º ÀÖ´Â °á°ú¸¦ ¾ò±â À§Çؼ­´Â »ç¿ëÇÏ´Â ¼¼Æ÷, Ç׿ø, Ç×ü¸¦ ÁÖÀÇ ±í°Ô °ü¸®ÇØ¾ß ÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ:

¼¼°è ¸é¿ªÁ¶Á÷È­ÇÐ ½ÃÀåÀº ÁÖ·Î ³ëÀÎ Àα¸ÀÇ Áõ°¡¿Í ÀÌ¿¡ µû¸¥ ¸¸¼ºÁúȯ ¹× °¨¿°¼º ÁúȯÀÇ À¯º´·ü Áõ°¡¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)ÀÇ 2022³â 10¿ù º¸°í¼­¿¡ µû¸£¸é, Àü ¼¼°è 60¼¼ ÀÌ»ó Àα¸ÀÇ ºñÀ²Àº 2015³â¿¡¼­ 2050³â »çÀÌ¿¡ 12%¿¡¼­ 22%·Î °ÅÀÇ µÎ ¹è·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Àü ¼¼°è ¾Ï ¹ßº´·üÀÇ Áõ°¡´Â ¾Ï Áø´Ü ¹× ¿¹ÈÄ¿Í °ü·ÃµÈ ¹ÙÀÌ¿À¸¶Ä¿¸¦ °ËÃâÇÏ´Â IHC ºÐ¼®¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ±×·¯³ª IHC Áø´Ü ŰƮ ½ÂÀο¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©¿Í ƯÈ÷ ½ÅÈï±¹ÀÇ ¼÷·ÃµÈ Àη ºÎÁ·Àº ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖÀ¸¸ç, IHC ¿°»öÀÇ ÀÚµ¿ Á¤·®È­¿Í º¸´Ù Á¤È®ÇÑ ºÐ¼®À» À§ÇÑ ÀΰøÁö´ÉÀÇ ÅëÇÕÀ» Á¦°øÇÏ´Â µðÁöÅÐ º´¸® ¼Ö·ç¼ÇÀÇ ÃâÇöÀº ½ÃÀå ±â¾÷¿¡ À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • ¼¼°èÀÇ ¸é¿ªÁ¶Á÷È­ÇÐ ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â)ÀÇ ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» Á¶»çÇÏ¿© Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
  • ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­´Â ȸ»ç ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ¸é¿ªÁ¶Á÷È­ÇÐ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ¸é¿ªÁ¶Á÷È­ÇÐ ¼¼°è ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü°¡ÀÚ, À繫 ºÐ¼®°¡ µî ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ¸é¿ªÁ¶Á÷È­ÇÐ ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú °¡Á¤

  • Á¶»ç ¸ñÀû
  • °¡Á¤
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ½ÃÀå ±âȸ
  • ¿µÇ⠺м®
  • ÆÄÀÌÇÁ¶óÀÎ ºÐ¼®
  • PEST ºÐ¼®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • ½ÃÀå µ¿Çâ
  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ÀμöÇÕº´

Á¦4Àå ¼¼°èÀÇ ¸é¿ªÁ¶Á÷È­ÇÐ ½ÃÀå - COVID-19 ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • °æÁ¦¿¡ ´ëÇÑ ¿µÇâ
  • ÀÓ»ó½ÃÇè¿¡ ´ëÇÑ ¿µÇâ
  • Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê

Á¦5Àå ¼¼°èÀÇ ¸é¿ªÁ¶Á÷È­ÇÐ ½ÃÀå, Á¦Ç°º°, 2020-2032³â

  • Ç×ü
  • 1Â÷ Ç×ü
  • 2Â÷ Ç×ü
  • ½Ã¾à
  • ´Ü¹éÁú ºÐÇØ È¿¼Ò
  • °íÁ¤ ½Ã¾à
  • Á¶Á÷ÇÐÀû ¿°»ö
  • Èñ¼®Á¦
  • ±âŸ
  • Àåºñ
  • ½½¶óÀÌµå ¿°»ö ½Ã½ºÅÛ
  • Á¶Á÷ ó¸® ½Ã½ºÅÛ
  • ½½¶óÀÌµå ½ºÄ³³Ê
  • ±âŸ Àåºñ
  • ŰƮ

Á¦6Àå ¼¼°èÀÇ ¸é¿ªÁ¶Á÷È­ÇÐ ½ÃÀå, ¿ëµµº°, 2020-2032³â

  • Áø´Ü
  • ¾Ï
  • °¨¿°Áõ
  • ÀÚ°¡¸é¿ªÁúȯ
  • ½Å°æÁúȯ
  • ±âŸ Áúȯ
  • ¿¬±¸
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ ¸é¿ªÁ¶Á÷È­ÇÐ ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020-2032³â

  • º´¿ø
  • Áø´Ü °Ë»ç½Ç
  • ÇмúÁ¶»ç±â°ü
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ ¸é¿ªÁ¶Á÷È­ÇÐ ½ÃÀå, Áö¿ªº°, 2020-2032³â

  • ºÏ¹Ì
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿
  • ¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï ±¸µµ

  • È÷Æ®¸Ê ºÐ¼®
  • ½ÃÀå Á¡À¯À² ºÐ¼®
    • Merck KGaA
    • Rockland Immunochemical, Inc.
    • F. Hoffman-La Roche Ltd
    • Thermo Fisher Scientific
    • PerkinElmer, Inc.
    • Bio-Rad Laboratories, Inc.
    • Cell Signaling Technology, Inc.
    • Bio SB
    • Agilent Technologies, Inc.
    • Abcam plc.
    • Bectom, Dickson and Company
    • Miltenyi Biotec
    • Biocare Medical, LLC
    • Eagle Bioscience, Inc.
    • Bio Techne
    • Diagnostic Biosystems, Inc.
    • BioGenex

Á¦10Àå ¾Ö³Î¸®½ºÆ®ÀÇ °üÁ¡

  • Wheel of Fortune
  • ¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ
  • Coherent Opportunity Map

Á¦11Àå Âü°í¹®Çå°ú Á¶»ç ¹æ¹ý

  • Âü°í¹®Çå
  • Á¶»ç ¹æ¹ý
ksm 25.04.08

Global Immunohistochemistry Market is estimated to be valued at USD 3.07 Bn in 2025 and is expected to reach USD 4.84 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.7% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 3.07 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.70% 2032 Value Projection: USD 4.84 Bn
Figure. Immunohistochemistry Market Share (%), By Region 2025
Immunohistochemistry Market - IMG1

Immunohistochemistry (IHC) is a technique used to detect antigens in cells of a tissue section by exploiting the principle of antibodies binding specifically to antigens in biological tissues. IHC enables researchers to identify cell types and locations of biomarkers as well as the distribution of target antigens in normal and diseased tissues. It helps in disease diagnosis, prognostic evaluation, and predictive and personalized medicine. IHC uses affinity between antibodies and antigens for making specific proteins in cells of a tissue sample visible microscopically, thus aiding in the identification of cell type and localization of biomolecules. The cells, antigens, and antibodies used must be carefully controlled to ensure accurate and reproducible results.

Market Dynamics:

The global immunohistochemistry market is primarily driven by the rising geriatric population and associated increase in prevalence of chronic and infectious diseases. According to the World Health Organization (WHO) October 2022 report, the proportion of the world's population over 60 years will nearly double from 12% to 22% between 2015 and 2050. The growing incidence of cancer worldwide is also boosting the demand for IHC assays to detect biomarkers related to cancer diagnosis and prognosis. However, stringent regulatory frameworks for the approval of IHC diagnostic kits and lack of skilled personnel especially in developing nations are some challenges restraining the market growth. The emergence of digital pathology solutions offering automated quantification of IHC staining and integration of Artificial Intelligence for more accurate analysis present lucrative opportunities for market players.

Key Features of the Study:

  • This report provides an in-depth analysis of the global immunohistochemistry market, and provides market size (USD BN) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global immunohistochemistry market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Merck KGaA, Rockland Immunochemicals Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, PerkinElmer Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB, Agilent Technologies Inc., Abcam plc., Becton Dickinson and Company, Miltenyi Biotec, Biocare Medical LLC, Eagle Biosciences Inc., Bio-Techne, Diagnostic Biosystems Inc., and BioGenex.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global immunohistochemistry market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immunohistochemistry market.

Market Segmentation

  • Product:
    • Antibodies
    • Primary Antibodies
    • Secondary Antibodies
    • Reagents
    • Proteolytic Enzymes
    • Fixation Reagents
    • Histological Stains
    • Diluents
    • Others
    • Equipment
    • Slide-staining systems
    • Tissue Processing Systems
    • Slide Scanners
    • Other Equipment
    • Kits
  • Application:
    • Diagnostics
    • Cancer
    • Infectious Diseases
    • Autoimmune Diseases
    • Neurological Diseases
    • Others Diseases
    • Research
    • Others
  • End User:
    • Hospitals
    • Diagnostics Laboratories
    • Academic & Research Institutes
    • Others
  • Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Merck KGaA
    • Rockland Immunochemicals Inc.
    • Hoffmann-La Roche Ltd
    • Thermo Fisher Scientific
    • PerkinElmer Inc.
    • Bio-Rad Laboratories Inc.
    • Cell Signaling Technology Inc.
    • Bio SB
    • Agilent Technologies Inc.
    • Abcam plc.
    • Becton Dickinson and Company
    • Miltenyi Biotec
    • Biocare Medical LLC
    • Eagle Biosciences Inc.
    • Bio-Techne
    • Diagnostic Biosystems Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Pipeline Analysis
  • PEST Analysis
  • Regulatory Scenario
  • Market Trends
  • Key Highlights
  • Mergers & Acquisitions

4. Global Immunohistochemistry Market - Impact of Coronavirus (COVID-19) Pandemic

  • Economic Impact
  • Impact on Clinical Trials
  • Government Initiatives

5. Global Immunohistochemistry Market, By Product Type, 2020 - 2032, (USD BN)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Antibodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)
  • Primary Antibodies
  • Secondary Antibodies
  • Reagents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)
  • Proteolytic Enzymes
  • Fixation Reagents
  • Histological Stains
  • Diluents
  • Others
  • Equipment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)
  • Slide-staining systems
  • Tissue Processing Systems
  • Slide Scanners
  • Other Equipment
  • Kits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)

6. Global Immunohistochemistry Market, By Application, 2020 - 2032, (USD BN)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)
  • Cancer
  • Infectious Diseases
  • Autoimmune Diseases
  • Neurological Diseases
  • Others Diseases
  • Research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)

7. Global Immunohistochemistry Market, By End User, 2020 - 2032, (USD BN)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)
  • Academic & Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)

8. Global Immunohistochemistry Market, By Region, 2020 - 2032, (USD BN)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Regions, 2020-2032
  • North America
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD BN)
      • U.S.
      • Canada
  • Latin America
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD BN)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD BN)
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD BN)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD BN)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, (USD BN)
      • South Africa
      • Central Africa
      • North Africa

9. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • Merck KGaA
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Rockland Immunochemical, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • F. Hoffman-La Roche Ltd
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Thermo Fisher Scientific
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • PerkinElmer, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Bio-Rad Laboratories, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Cell Signaling Technology, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Bio SB
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Agilent Technologies, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Abcam plc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Bectom, Dickson and Company
    • Miltenyi Biotec
    • Biocare Medical, LLC
    • Eagle Bioscience, Inc.
    • Bio Techne
    • Diagnostic Biosystems, Inc.
    • BioGenex

10. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦